The Role of MET in Resistance to EGFR Inhibition in NSCLC: A Review of Mechanisms and Treatment Implications

SIMPLE SUMMARY: In non-small cell lung cancer that has spread to other locations in the body, identifying genetic abnormalities in a patient’s cancer has allowed for the development of targeted treatments. For cancers that have genetic changes in epidermal growth factor receptor (EGFR), treatments s...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldt, Susan L., Bestvina, Christine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251884/
https://www.ncbi.nlm.nih.gov/pubmed/37296959
http://dx.doi.org/10.3390/cancers15112998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251884/
https://www.ncbi.nlm.nih.gov/pubmed/37296959
http://dx.doi.org/10.3390/cancers15112998

Ejemplares similares